KALA BIO, Inc.
KALA
$0.57
$0.011.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.47% | -336.30% | 109.07% | 32.19% | -24.68% |
| Total Depreciation and Amortization | -- | -- | -57.81% | 91.04% | -1.47% |
| Total Amortization of Deferred Charges | -- | -- | -509.48% | -32.95% | -6.99% |
| Total Other Non-Cash Items | -110.59% | 137.40% | -167.78% | -151.55% | 2.73% |
| Change in Net Operating Assets | 107.11% | -84.29% | 38.99% | -427.81% | 127.19% |
| Cash from Operations | 46.98% | 36.46% | 58.11% | -40.64% | 12.35% |
| Capital Expenditure | -- | -- | -100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -100.00% | 106.25% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -66,290.00% | 98.81% | -8,935.71% |
| Issuance of Common Stock | -- | -- | 15,123.33% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | 127.89% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -100.00% | 145.66% | -30,043.33% | 101.19% | -1,774.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.50% | 57.21% | -24.83% | -5.51% | -14.74% |